Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice

Infection and Immunity

Volumn 72, Issue 10, 2004, Pages 5931-5937

  Abreu, Patrícia A E ^a   Miyasato, Patrícia A ^a   Vilar, Mônica M ^b   Dias, Waldely O ^a   Ho, Paulo L ^a   Tendler, Míriam ^b   Nascimento, Ana L T O ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; HISTIDINE; HYBRID PROTEIN; MULTIVALENT RECOMBINANT VACCINE; NICKEL; PHOSPHATE; PROTEIN SM14; RECOMBINANT VACCINE; SCHISTOSOMA VACCINE; SODIUM CHLORIDE; TETANUS ANTIBODY; TETANUS TOXIN; TETANUS TOXIN FRAGMENT C; TETANUS TOXOID; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CERCARIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; IMMUNIZATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SURVIVAL; SYMPTOM; TETANUS; TH2 CELL; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, HELMINTH; CARRIER PROTEINS; FATTY ACID TRANSPORT PROTEINS; HELMINTH PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SURVIVAL RATE; TETANUS; TETANUS TOXIN; VACCINATION; VACCINES; VACCINES, SYNTHETIC;

EID: 4644357064     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.10.5931-5937.2004     Document Type: Article

References (25)

1. Areas, A. P. M., M. L. S. Oliveira, C. R. R. Ramos, M. E. Sbrogio-Almeida, I. Raw, and P. L. Ho. 2002. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli. Protein Expr. Purif. 25:481-487.
2. Bergquist, N. R. February 2004, posting date. Prospects for schistosomiasis vaccine development. WHO TDRnews 71. [Online.] http://who.int/tdr/publication/tdrnews/news71/schisto.html.
3. Bergquist, N. R., and D. G. Colley. 1998. Schistosomiasis vaccines: research to development. Parasitol. Today 14:99-104.
4. Bergquist, P., M. Al-Sherbiny, R. Barakat, and R. Olds. 2002. Blueprint for schistosomiasis vaccine development. Acta Trop. 82:183-192.
5. Bhandari, P., and J. Gowrishankar. 1997. An Escherichia coli host strain useful for efficient overproduction of cloned gene products with NaCl as the inducer. J. Bacteriol. 179:4403-4406.
6. Boucher, P., H. Sato, Y. Sato, and C. Locht. 1994. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of recombinant pertussis toxin-tetanus toxin fusion protein. Infect. Immun. 62:449-456.
7. Chabalgoity, J. A., C. M. A. Khan, A. A. Nash, and C. E. Hormaeche. 1996. A Salmonella enterica serovar Typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol. Microbiol. 19:791-801.
8. Chabalgoity, J. A., J. A. Harrison, A. Esteves, R. D. de Hormaeche, R. Ehrlich, C. M. A. Khan, and C. E. Hormaeche. 1997. Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains. Infect. Immun. 65:2402-2412.
9. Fairweather, N. F., V. A. Lyness, and D. J. Maskell. 1987. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect. Immun. 55:2541-2545.
10. Figueiredo, D., C. Turcotte, G. Frankel, Y. Li, O. Dolly, G. Wilkin, D. Marriot, N. Fairweather, and G. Dougan. 1995. Characterization of recombinant tetanus toxin derivatives suitable for vaccine development. Infect. Immun. 63:3218-3221.
11. Gómez-Duarte, O. G., J. Galen, S. N. Chatfield, R. Rappuoli, L. Eidels, and M. M. Levine. 1995. Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain. Vaccine 13:1596-1602.
12. Ismail, M., S. Botros, A. Metwally, S. William, A. Farghally, L. F. Tao, T. A. Day, and J. L. Bennett. 1999. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60:932-935.
13. Khan, C. M. A., B. Villareal-Ramos, R. J. Pierce, G. Riveau, R. de Hormaeche, H. McNeill, T. Ali, N. Fairweather, S. Chatfield, A. Capron, G. Dougan, and C. E. Hormaeche. 1994. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc. Natl. Acad. Sci. USA 91:11261-11265.
14. Lee, J. J., K. A. Sinha, J. A. Harrison, R. D. de Hormaeche, G. Riveau, R. J. Pierce, A, Capron, R. A. Wilson, and C. M. A. Khan. 2000. Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase. Infect. Immun. 68:2503-2512.
15. Montecucco, C., and G. Schiavo. 1995. Structure and function of tetanus and botulinum neurotoxins. Q. Rev. Biophys. 28:423-472.
16. Ramos, C. R., M. M. Vilar, A. L. Nascimento, P. L. Ho, N. Thaumaturgo, R. Edelenyi, M. Almeida, W. O. Dias, C. M. Diogo, and M. Tendler. 2001. r-Sm14-pRSETA efficacy in experimental animals. Mem. Inst. Oswaldo Cruz 96:131-135.
17. Ramos, C. R. R., R. C. R. Figueiredo, T. A. Perttinhez, M. M. Vilar, A. L. T. O. Nascimento, M. Tendler, I. Raw, A. Spisni, and P. L. Ho. 2003. Gene structure and M20T polymorphism of the Schistosoma mansoni Sm14 fatty acid-binding protein. J. Biol. Chem. 278:12745-12751.
18. Ribas, A. V., P. L. Ho, M. M. Tanizaki, I. Raw, and A. L. T. O. Nascimento. 2000. High-level expression of tetanus toxin fragment C-thioredoxin fusion in Escherichia coli. Biotechnol. Appl. Biochem. 31:91-94.
19. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
20. Tendler, M., C. A. Brito, M. V. Vilar, N. Serra-Freire, C. M. Diogo, M. S. Almeida, A. C. B. Delbem, J. F. da Silva, W. Savino, R. C. Garrati, N. Katz, and A. J. Simpson. 1996. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose antihelminth vaccine. Proc. Natl. Acad. Sci. USA 93:269-273.
21. Turton, K., J. A. Chaddock, and R. Archarya. 2002. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem. Sci. 27:552-558.
22. Verjovski-Almeida, S., R. DeMarco, E. A. Martins, P. E. Guimaraes, E. P. Ojopi, A. C. Paquola, J. P. Piazza, M. Y. Nishiyama, Jr., J. P. Kitajima, R. E. Adamson, P. D. Ashton, M. F. Bonaldo, P. S. Coulson, G. P. Dillon, L. P. Farias, S. P. Gregorio, P. L. Ho, R. A. Leite, L. C. Malaquias, R. C. Marques, P. A. Miyasato, A. L. Nascimento, F. P. Ohlweiler, E. M. Reis, M. A. Riheiro, R. G. Sa, G. C. Stukart, M. B. Soares, C. Gargioni, T. Kawano, V. Rodrigues, A. M. Madeira, R. A. Wilson, C. F. Menck, J. C. Setubal, L. C. Leite, and E. Dias-Neto. 2003. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat. Genet. 35:148-157.
23. Vilar, M. M., F. B. Barrientos, M. Almeida, N. Thaumaturgo, A. Simpson, R. Garratt, and M. Tendler. 2003. An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis. Vaccine 22:137-144.
24. World Health Organization. 2002. The prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of the Joint WHO Expert Committees. World Health Organization, Geneva, Switzerland.
25. World Health Organization. 1977. Manual for the production and control of vaccines. BLG/UNDP/72.2 Rev. 1, 79. WHO, Geneva, Switzerland.